Zobrazeno 1 - 10
of 692
pro vyhledávání: '"S, Miotti"'
Autor:
Kesharwani, Prashant1 (AUTHOR) prashantdops@gmail.com, Halwai, Kratika1 (AUTHOR), Jha, Saurav Kumar2 (AUTHOR), AL Mughram, Mohammed H.3 (AUTHOR), Almujri, Salem Salman4 (AUTHOR), Almalki, Waleed H.5 (AUTHOR), Sahebkar, Amirhossein6,7 (AUTHOR) amir_saheb2000@yahoo.com
Publikováno v:
Molecular Cancer. 10/31/2024, p1-51. 51p.
Autor:
Deng, Junwen1,2 (AUTHOR) 2021021179@qdu.edu.cn, Geng, Zhongmin1,2 (AUTHOR) gzmin-qdu@qdu.edu.cn, Luan, Linli3 (AUTHOR) ll0527ll@163.com, Jiang, Dingwen3 (AUTHOR) jiangdingwen@auambio.com, Lu, Jian3 (AUTHOR) luj@noventi.com.cn, Zhang, Hanzhong1,2 (AUTHOR) zhz17805982993@163.com, Chen, Bingguan3 (AUTHOR) chenbg@noventi.com.cn, Liu, Xinlin1,2 (AUTHOR) lxl2021910024@qdu.edu.cn, Xing, Dongming1,2,4 (AUTHOR) lxl2021910024@qdu.edu.cn
Publikováno v:
Pharmaceutics. Oct2024, Vol. 16 Issue 10, p1255. 20p.
Autor:
Alfawaz, Mohammed1 maalfawaz@uj.edu.sa
Publikováno v:
Bahrain Medical Bulletin. Sep2024, Vol. 46 Issue 3, p2344-2348. 5p.
Publikováno v:
Journal of cellular biochemistry. 81(3)
The alpha-folate receptor (alpha FR) is overexpressed in 90% of nonmucinous ovarian carcinomas. In addition to the known role of alpha FR binding and mediating the internalization of folates, functional interaction of alpha FR with signaling molecule
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c26799e07db9953024ac38e12f236c2b
https://pubmed.ncbi.nlm.nih.gov/11255231
https://pubmed.ncbi.nlm.nih.gov/11255231
Autor:
S, Miotti, D R, Negri, O, Valota, M, Calabrese, R L, Bolhuis, J W, Gratama, M I, Colnaghi, S, Canevari
Publikováno v:
International journal of cancer. 84(1)
More than 60% of cancer patients injected with intact murine monoclonal antibody (MAb) develop a humoral response against the antigen even after a single dose. Analysis of a series of 35 ovarian-cancer patients entered in phase-I and -II clinical stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::72df6cea51dd08cde76db837067729ad
https://pubmed.ncbi.nlm.nih.gov/9988234
https://pubmed.ncbi.nlm.nih.gov/9988234
Publikováno v:
International journal of cancer. 79(2)
Overexpression of the folate binding protein (FBP) is a common feature in epithelial ovarian cancer, but its prognostic significance is not clearly understood. We investigated whether FBP in epithelial ovarian cancer specimens is a predictor of respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7e9fcf823ef5d16e4cd55f7c936e808b
https://pubmed.ncbi.nlm.nih.gov/9583724
https://pubmed.ncbi.nlm.nih.gov/9583724
Autor:
V, Dolo, A, Ginestra, S, Violini, S, Miotti, C, Festuccia, D, Miceli, M, Migliavacca, C, Rinaudo, F M, Romano, F, Brisdelli, S, Canevari, A, Pavan, M L, Vittorelli
Publikováno v:
Oncology research. 9(3)
We have established an ovarian cancer cell line (CABA I) from ascitic fluid obtained from a patient with papillary adenocarcinoma of the ovary prior to drug treatment. The epithelial origin of the cell line was confirmed by morphology and by immunofl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b414aebe71b92c10431621c05bbc9282
https://pubmed.ncbi.nlm.nih.gov/9220498
https://pubmed.ncbi.nlm.nih.gov/9220498
Publikováno v:
Cancer research. 53(23)
The glycoprotein gp38 is overexpressed in 90% of ovarian carcinomas and recognized by monoclonal antibodies MOv18 and MOv19. This molecule is a high affinity folate binding protein (FBP) and a potential marker for ovarian carcinoma. We have developed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6ab4d3037e614d3f84e21cee1abc327c
https://pubmed.ncbi.nlm.nih.gov/8242637
https://pubmed.ncbi.nlm.nih.gov/8242637
Publikováno v:
International journal of cancer. 54(2)
By immunizing a BALB/c mouse with a human ovary-carcinoma cell line (IGROV1), grown intraperitoneally in nude mice, a monoclonal antibody (MAb), designated MAR6, was produced and characterized. Immunofluorescence on the immunizing cell line showed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1ed295da13634e94b29b784f1d598523
https://pubmed.ncbi.nlm.nih.gov/8486429
https://pubmed.ncbi.nlm.nih.gov/8486429
Autor:
R L, Bolhuis, C H, Lamers, S H, Goey, A M, Eggermont, J B, Trimbos, G, Stoter, A, Lanzavecchia, E, di Re, S, Miotti, F, Raspagliesi
Publikováno v:
International journal of cancer. Supplement = Journal international du cancer. Supplement. 7
A bispecific monoclonal antibody (bs-MAb) (OC/TR) was produced in large quantities for the intraperitoneal (i.p.) treatment of ovarian cancer. The bs-MAb recognizes the folate-binding protein on ovarian cancer cells on the one hand and the CD3 activa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2221c3c1a72e4a2826e769350620adb0
https://pubmed.ncbi.nlm.nih.gov/1428412
https://pubmed.ncbi.nlm.nih.gov/1428412